BlueStone invests in early-stage startups that operate within the Life Sciences. The Fund primarily focuses on companies that reside within our "Core Four" verticals which are: Medical Devices, Diagnostics, Digital Health, and
Life Science Research Tools.
We seek companies that have developed transformative platforms or disruptive technologies, are protected by strong intellectual property, and will have a meaningful impact on healthcare. Our preference is for companies residing in the NATO States (New Mexico, Arizona, Texas, and Oklahoma), however, as a return-driven fund, we will make investments in US based companies regardless of geography if they fit our “Southwest-like” metrics.
BlueStone provides growth capital and strategic support to our portfolio companies in addition to privileged access to strategic partners including investors, customers, and other partners residing within the supply chain.
Copyright 2022 © BlueStone Venture Partners